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Abstract
Background: Oct4 is a key factor of an expanded transcriptional network (Oct4-TN) that governs pluripotency and
self-renewal in embryonic stem cells (ESCs) and in the inner cell mass from which ESCs are derived. A pending
question is whether the establishment of the Oct4-TN initiates during oogenesis or after fertilisation. To this regard,
recent evidence has shown that Oct4 controls a poorly known Oct4-TN central to the acquisition of the mouse
egg developmental competence. The aim of this study was to investigate the identity and extension of this
maternal Oct4-TN, as much as whether its presence is circumscribed to the egg or maintained beyond fertilisation.
Results: By comparing the genome-wide transcriptional profile of developmentally competent eggs that express
the OCT4 protein to that of developmentally incompetent eggs in which OCT4 is down-regulated, we unveiled a
maternal Oct4-TN of 182 genes. Eighty of these transcripts escape post-fertilisation degradation and represent the
maternal Oct4-TN inheritance that is passed on to the 2-cell embryo. Most of these 80 genes are expressed in
cancer cells and 37 are notable companions of the Oct4 transcriptome in ESCs.
Conclusions: These results provide, for the first time, a developmental link between eggs, early preimplantation
embryos and ESCs, indicating that the molecular signature that characterises the ESCs identity is rooted in
oogenesis. Also, they contribute a useful resource to further study the mechanisms of Oct4 function and regulation
during the maternal-to-embryo transition and to explore the link between the regulation of pluripotency and the
acquisition of de-differentiation in cancer cells.
Background
The first cell divisions of the preimplantation embryo
rely on a number of maternal-effect factors that have
been stored in the egg throughout folliculogenesis and
that guide early development during the maternal-to-
embryo transition, when embryonic genome activation
(EGA) occurs and novel transcripts and proteins are
produced as a requirement for further development [1].
If the expression of single maternal-effect genes is
experimentally altered during mouse oogenesis or in the
zygote, most of the embryos arrest development at the
2-cell stage or a few cell divisions later in preimplanta-
tion [2]. A question that remains unanswered is con-
cerned with the nature of the transcriptional networks
(TN) in which maternal-effect genes operate. This
knowledge would further our understanding of the
molecular identity of a developmentally competent egg
(metaphase II, MII, oocyte) and would allow to investi-
gate how this identity is modified during the switch to
an embryonic control of development.
Oct4 (Pou5f1, POU domain, class 5, transcription fac-
tor 1) is one of the 27 maternal-effect genes reported so
far [2] whose transcripts inherited by the zygote are
necessary for development beyond the 2-cell stage [3].
Most of our knowledge on Oct4 functions comes from
studies that describe its key role in the control of tran-
scriptional regulatory circuits that maintain pluripotency
in the inner cell mass (ICM) of the blastocyst [4] and in
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embryonic stem cells (ESCs) [5-10]. Furthermore, OCT4
is recognised for its capacity, when ectopically expressed
in combination with other transcription factors (i.e.,
NANOG, SOX2, cMYC, KLF4 or ESRRB), to reprogram
differentiated cells into pluripotent cells (induced pluri-
potent stem cells, iPS cells) [11-15].
Recent studies have also shown a role for OCT4 in
the acquisition of the egg developmental competence
[16,17]. During oocyte growth the OCT4 protein is
first detected at the time of follicle recruitment, only
in one of two major classes of oocytes present in the
mouse ovary, named surrounded nucleolus (SN)
oocytes and recognisable for the presence of a ring of
heterochromatin surrounding their nucleolus; on the
contrary, OCT4 expression is comparativelly down-
regulated in NSN (not surrounded nucleolus) oocytes
that lack of a ring of heterochromatin around the
nucleolus [18-22]. This distinct pattern of expression is
maintained throughout oocyte growth, in fully matured
antral SN and NSN oocytes and in their derived MIISN
and MIINSN oocytes, respectively [17]. The most strik-
ing difference between these two categories of oocytes
is that only MIISN oocytes may develop beyond the 2-
cell stage and reach full term development [23-25].
OCT4 down-regulation in MIINSN oocytes correlates
with the down-regulation of the maternal-effect factor
STELLA [26] and with the up-regulation of eighteen
OCT4-regulated genes that are part of a gene expres-
sion network implicated in mitochondrial dysfunction
and apoptosis [16], explaining the developmental block
encountered by 2-cell embryos obtained from MIINSN
oocytes (2-cellNSN). This data indicate that Oct4 is an
important component of a maternal regulatory TN
that influences positively (when Oct4 is expressed) or
negatively (when Oct4 is down-regulated) the oocyte
developmental competence. The molecular identity
and extension of this TN, as much as whether its pre-
sence is circumscribed to the egg or, after fertilisation,
is maintained beyond the first mitotic division, remains
to be understood.
In the present study, by comparing the genome-wide
transcriptional profile of ovulated MII oocytes that
express the OCT4 protein (MII control, MIIctrl) to that
of MII oocytes in which OCT4 is comparativelly down-
regulated (MIINSN), we unveiled an expanded maternal
Oct4-TN made of 182 genes. Then, by comparing the
transcriptional profile of 2-cell embryos derived from
MIIctrl oocytes (2-cellctrl) to that of embryos derived
from MIINSN oocytes (2-cellNSN), we showed that the
Oct4-TN has a core group of 80 genes that remains
expressed beyond fertilisation and the first segmentation
division. Of these 80 genes, 37 are notable companions
of the Oct4 transcriptome in ESCs and the majority is
expressed in cancer cells.
Results
Gene expression profiles of developmentally incompetent
and competent MII oocytes or 2-cell embryos
To highlight genes with altered expression (up- or
down-regulated) in developmentally incompetent
MIINSN oocytes, we first compared their transcription
profile with that of MIIctrl oocytes using microarray data
from our previous work [17]. The data lists obtained
earlier were revised since the data banks from which
information was recovered are constantly updated.
A list of regulated and annotated genes or gene
sequences (from now on named genes) was retrieved
after setting a 1.5 fold-change threshold and a detection
p value ≤ 0.01. Using the Gene Ontology (GO) enrich-
ment analysis tool provided by the data mining and
bioinformatics software Orange http://www.ailab.si/
orange, 3102 (Additional file 1) out of 8354 regulated
genes were assigned to seven major biological processes
(Figure 1A), including development, cellular and
Figure 1 Microarray-based analysis of the transcription profile
of developmentally incompetent and competent MII oocytes
and 2-cell embryos. (A) Major biological processes and functions
found when comparing the transcription profile of MIINSN vs. MIIctrl
oocytes and number of up- and down-regulated genes in each of
these processes. (B) Major biological processes and functions found
when comparing the transcription profile of 2-cellNSN vs. 2-cellctrl
embryos and number of up- and down-regulated genes in each of
these processes.
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macromolecule localisation, apoptosis, transcription,
intracellular signalling, cell cycle and translation. This
analysis showed that the great majority of these genes
were up-regulated in MIINSN oocytes (Figure 1A).
Next, using the same fold-change and p value thresh-
olds, we generated another list of regulated genes by
comparing the transcription profile of 2-cellNSN vs. 2-
cellctrl embryos. Out of 3599 regulated genes, 1887
(Additional file 2) were assigned to thirteen major biolo-
gical processes. Figure 1B shows the number of up- and
down-regulated genes in each of these processes.
In summary, we retrieved two lists of regulated genes
that highlight the changes occurring to the transcrip-
tional signature of developmentally competent eggs or
2-cell embryos, when compared to their incompetent
counterparts. Our next step was aimed at the identifica-
tion of known Oct4-regulated genes within each of
these two lists.
A maternal Oct4 transcriptional network is constituent of
the molecular identity of both MII oocytes and 2-cell
embryos
Using mouse and human chip datasets of OCT4-regu-
lated genes in ESCs [5,27,28], we singled out a group of
32 OCT4-regulated genes whose transcripts were
detected in both the MII oocyte and 2-cell embryo
microarray lists. When compared to MIIctrl samples, the
great majority of these genes were up-regulated in
developmentally incompetent MIINSN oocytes in which
the OCT4 protein is markedly down-regulated (Figure
2), suggesting a down-regulatory function of this tran-
scription factor over these genes. By comparing 2-
cellNSN with 2-cellctrl embryos, we found that the
expression of the majority of this group of 32 genes was
higher in the latter (Figure 2), indicating that the down-
regulatory function of OCT4 had been released. In fact,
following fertilisation, the maternal OCT4 protein pre-
sent in MIIctrl oocytes is carried over into the zygote
and by the 2-cell stage becomes undetectable [29], to
reappear again, expressed from the embryonic genome,
at the 8-cell stage [30].
The hypergeometric test confirmed that the up- and
down-regulated pattern of expression of 20 of these
OCT4-regulated genes in MIINSN oocytes and 2-cellNSN
embryos (Figure 2), respectively, was not a stochastic
event, but instead a specific characteristic of this group
of genes at these two developmental stages (p = 0.0039).
The results of the microarray analysis for five of these
genes were confirmed by qRT-PCR (Additional file 3).
Of these 20 OCT4-regulated genes, we analysed the
expression profile of those proteins for which an antibody
was commercially available, i.e., DNMT3L1, RPS20 and
MCL1 (MCL1 antibody did not give consistent results and
therefore was not used further, data not shown).
DNMT3L is a crucial factor for the establishment of geno-
mic imprinting in oocytes and the expression of Dnmt3l
increases during preimplantation in both mouse and rhe-
sus monkey, suggesting a developmental role [31]. RPS20
is a ribosomal protein involved in translation and its role
in preimplantation as never been investigated before.
Immunolabeling of DNMT3L and RPS20 antibodies was
positive in MIINSN oocytes (Figure 3A) and 2-cellctrl (Fig-
ure 3B), whereas it was negative in MIIctrl (Figure 3A) and
2-cellNSN embryos (Figure 3B), confirming the reversal
pattern of expression described for their transcripts during
the passage from the egg to the 2-cell stage.
Our next step was aimed at determining whether the
Oct4-TN could be further expanded and better
characterised.
Figure 2 List of OCT-4-regulated genes expressed in both MII
oocytes and 2-cell embryos. Comparison of gene expression is
made between MIINSN vs. MIIctrl or 2-cellNSN vs. 2-cellctrl. Red box,
up-regulated; green box, down-regulated; blank box, not
differentially expressed. The hypergeometric test proved that the
up- (MIINSN oocytes) and down-regulated (2-cellNSN embryos)
pattern of expression of the majority genes (*) was not a stochastic
event (p = 0.0039).
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Numerous genes of the maternal Oct4 transcriptional
network are known members of the Oct4 interactome in
ESCs
Using the Network Explorer module provided by the
Orange software (see Methods for details), we explored
public databases for links (based on GO and MeSH,
Medical Subject Headings, terms) between the group of
32 OCT4-regulated genes used as bait (with the addition
of Oct4), and all the annotated mouse gene sequences.
This search retrieved an annotation network made of a
total of 312 genes (Additional file 4), 197 of which were
components (i.e., expressed) of our MII oocyte and/or
2-cell embryo list of regulated genes. This network was
combined with the results of gene expression differential
analysis to infer transcriptional relationships among the
genes of an expanded Oct4-TN. The expanded Oct4-
TN, made of 197 genes (Figure 4), comprised 102 genes
expressed exclusively in MII oocytes (Additional file 5),
15 genes solely in 2-cell embryos (Additional file 6) and
80 genes in both MII oocytes and 2-cell embryos (from
now onwards named Oct4-OETN, Oocyte-to-Embryo
Transcriptional Network; Figure 5). The Oct4-OETN
contained all the 32 OCT4-regulated genes, except 4
that were not annotated and thus excluded; most (20) of
the remaining 28 genes were up-regulated in MIINSN
oocytes but down-regulated in 2-cellNSN embryos.
Besides these 28 OCT4-regulated genes, the Oct4-
OETN included 8 more genes of a recently published
list of OCT4-correlated transcripts expressed in ESCs
[32] (Figure 5) and 44 genes for which a direct or indir-
ect action of OCT4 on their expression will need to be
further investigated.
When compared to their respective control samples,
more than half of the Oct4-OETN genes (51 out of 80)
were up-regulated in MIINSN oocytes but down-regu-
lated (59 genes) in 2-cellNSN embryos; 7 genes were
down-regulated in oocytes and up-regulated in embryos,
whereas 22 and 14 genes where down- and up-regu-
lated, respectively, in both oocytes and embryos (Figure
5).
Among the 15 newly expressed genes, Dppa5 (Devel-
opmental pluripotency associated gene 5), Gata1 and
Zeb1 are the best known and their main functions will
be described in the section below.
In summary, this analysis brought to light in MII
oocytes, a maternal Oct4-TN made of 182 genes. Within
this circuitry, we could identify a restricted Oct4-OETN
made of 80 genes as core component common to the
molecular identity of both eggs and 2-cell embryos.
Almost half (37] of the Oct4-OETN genes are known
Oct4 companions in ESCs, as their expression is directly
regulated by [5,27,28] or correlated with [32]Oct4. Our
next step was aimed at investigating the main functional
characteristics of the genes and gene networks of the
expanded Oct4-TN.
Dissecting the expanded Oct4 transcriptional network
identifies nineteen gene clusters
The Oct4-TN was further analysed with the Network
Explorer module limiting to < 3 the number of sequen-
tial connections between one of the 28 OCT4-regulated
genes and the annotated neighbours. We identified 19
distinct gene clusters (Figure 6), each containing at least
one of the 80 Oct4-OETN genes. Based on GO annota-
tions and on a literature catalogues search, 18 of the 19
clusters could be ascribed to a major biological function.
A description of the main characteristics of each gene
cluster and of those Oct4-OETN genes for which func-
tional details were retrieved is given in Additional file 7
[33-92]. In summary, those Oct4-OETN genes for which
we could retrieve solid information fell into three main
categories with > 3 genes: 1) cancer, 18 genes (i.e.,
Rab39b, Rab35, Rab31, Rab21, Rab14, Rps15, Rps20,
Rps2, Atox1, Plagl1/Zac1, Foxp1, Foxm1, Nfat5, Cdt1,
Ring1B, Phc1, Tle1 and Atad3a); 2) preimplantation
development-pluripotency, 14 genes (i.e., Dppa4, Sall4,
Dnmt3b, Dnmt1, Dnmt3l, Dnmt3a, Ring1B, Scl4a8,
Plagl1/Zac1, Zhx1, Commd1/U2af1-rs1, Ooep, Filia and
Tle6); 3) cell division, 4 genes (i.e., Gpsm3, Cdt1, Skp1a
and Tipin). Among the poorly known genes remaining,
Figure 3 Immuno detection of the RPS20 and DNMT3L proteins
in MII oocytes and 2-cell embryos. (A) MIIctrl and MIINSN oocytes
and in (B) 2-cellctrl and 2-cellNSN embryos. (a, c, e, g and a’, c’, e’, g’),
antibodies staining; (b, d, f, h and b’, d’, f’, h’), merge between
antibodies staining and DAPI counterstaining. Scale bar, 20 μm.
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there is a group made of 7 genes (Bag4, Bat3, Bcl2l12,
Bcl2l13, Bcl2l2, Mcl1 and Relt) with apoptotic/anti-
apoptotic functions, whereas all the others could not be
grouped as they fell into several different categories,
each with less than three genes. This information
improves our understanding of the maternal Oct4-TN
composition, but also will serve as basic knowledge for
further dissection and future studies of its role in oogen-
esis and preimplantation development.
Most genes of the maternal Oct4 transcriptional network
are also expressed in cancer cells
Since one of the most abundant categories singled out
when dissecting the expanded Oct4-TN correlated with
cancer, we interrogated a more specific repository of
cancer-related genes, i.e., genes that, compared to con-
trols, are significantly up- or down-regulated in a wide
variety of solid and non-solid tumours (EBI Gene
Expression Atlas; http://www.ebi.ac.uk/gxa/). Strikingly,
the great majority, 157 out of 197 (79,7%) (Additional
file 8) of the expanded Oct4-TN and 65 out of 80 Oct4-
OETN genes (81.2%) (Additional file 9), were recognised
as cancer-related genes. The non-stochastic nature of
these frequencies was confirmed by the hypergeometric
test (p = 0.0031).
Discussion
Each cell type in our body has its own molecular iden-
tity defined by a number of transcriptional networks
that operate and cooperate to maintain the cell integrity
and a specific undifferentiated/differentiated status. Dur-
ing cell differentiation some transcriptional network die
out or fade one into another while guiding the cell
towards the acquisition of a specific phenotype. Tran-
scriptional inheritance is the load of transcripts and
active genes that are passed to the subsequent step of
differentiation. Likewise, the mammalian egg reaches the
fertilisation encounter with a transcriptional inheritance
Figure 4 Venn diagram illustrating distinct and overlapping gene expression patterns in MII oocytes and 2-cell embryos. Boxes, list of
genes belonging to each specific group; genes in bold, OCT4-regulated genes.
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representative of its developmental legacy. As part of
this molecular identity, in this study we brought to light
an Oct4-TN of maternal origin that is present during
the developmental period comprised between the MII
oocyte and the 2-cell embryo (Figure 7). As hereafter
described, these results allowed the generation of novel
hypotheses on the developmental role of a maternal
Oct4 transcriptional inheritance during the early stages
of mouse preimplantation development.
One marked phenomenon that occurs during the
developmental interval comprised between ovulation and
EGA is the inactivation or degradation of a considerable
number of transcripts mainly by processes of deadenyla-
tion [93], but also through the association with RNA-
binding proteins [94,95] and elimination by small silen-
cing RNAs that degrade mRNAs or repress their transla-
tion [96]. The maternal Oct4-TN that we identified has
its maximum expansion in MII oocytes, comprising 182
genes, then, following fertilisation, more than half (102)
of these transcripts are markedly down-regulated, to
become almost undetectable in 2-cell embryos, suggest-
ing their prompt degradation or deadenylation at the
beginning of development (our microarrays data were
obtained following oligo-dT retrotranscription that
amplified only polyadenylated transcripts, see M&M).
Interestingly, this group of genes includes Oct4, Sox2
(whose marked down-regulation in 2-cellctrl embryos has
already been described before) [97,98] and Klf4. Oct4,
Sox2 and Klf4 are central to the maintenance and promo-
tion of cell pluripotency [99]. Their down-regulation after
fertilisation may signal the execution of the egg develop-
mental programme (perhaps carried out by those Oct4-
OETN genes that survive degradation, see below), then,
at later stages of development, they are re-expressed, but
only in some blastomeres, namely those that will contri-
bute to the ICM, to induce their pluripotent status; on
the contrary, they are kept down-regulated in those cells
that will contribute to the trophectoderm. In support of
this hypothesis, a recent paper has demonstrated that
Oct4 re-expression occurs at the 8-cell stage embryo [30]
and is dissimilar in single blastomeres [100], suggesting a
possible different developmental commitment. The
developmental block encountered by 2-cellNSN embryos
could be associated (besides the up-regulation of apopto-
sis-related genes, as reported before [16,17]), to abnormal
expression or distribution of transcripts or proteins fol-
lowing the first segmentation [101]. To this regard, our
analysis of DNMT3L and RPS20, whilst demonstrating a
differential expression of both transcripts and proteins in
2-cellctrl vs. 2-cellNSN embryos, it did not evidence a dif-
ferential distribution in the two blastomeres (Figure 3),
although, at this stage, we cannot role out this hypothesis
because of the low sensitivity power of an immunocyto-
chemistry analysis.
Figure 5 Oct4 transcriptional network. Genes expressed in both
MII oocytes and 2-cell embryos. Green box, down-regulated; red
box, up-regulated; blue font, OCT4-regulated gene; highlighted in
grey, OCT4-correlated gene (Campbell et al., 2007).
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The 80 Oct4-OETN gene transcripts that survive the
massive post-fertilisation degradation represent the
maternal Oct4-TN inheritance that is passed from the
MII oocyte to the 2-cell embryo. Following fertilisation
some of the transcripts of these genes might be trans-
lated (as shown for the up-regulation of DNMT3L and
RPS20) and their proteins, together with those of the
group of 15 newly activated genes, may play a role
Figure 6 Gene clusters singled out in the expanded Oct4-TN. Green lines, MeSH annotations; orange lines, MeSH and GO annotations; grey
lines, GO annotations. Increasing line width indicates stronger annotation relationship.
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during the following stages of development. This core
Oct4-TN, that shares 37 genes with an OCT4 regulatory
network active in ESCs, might represent the molecular
signature of maternal origin on which the ESCs molecu-
lar identity is built up and tailored, thus providing a link
between eggs, early preimplantation embryos and ESCs
(Figure 8).
The expression of the OCT4 protein during oogenesis
first occurs at the time of follicle recruitment [17], when
oocytes have reached a size of approximately 30-40 μm
in diameter, suggesting that the beginning of the Oct4-
TN establishment might occur at this stage of oocyte
growth.
The significant presence of cancer-associated genes as
part of the Oct4 transcriptome is a theme shared with
ESCs [10,102], suggesting that an Oct4 circuitry may be
operating also in cancer cells and providing a molecular
link between the regulation of pluripotency and the
acquisition of dedifferentiation in cancer cells [103-107].
Furthermore, in view of the cancer stem cell hypothesis
[108], the presence of an Oct4-TN in cancer cells may
help the identification and characterisation of the stem
cell population within the tumor.
Conclusions
In this study we identified an Oct4-TN that is estab-
lished during oogenesis and that partially survives the
wide transcriptional erasure that occurs soon after ferti-
lisation. Its core Oct4-OETN circuitry of 80 genes is
maintained up to the 2-cell stage of development and
may represent part of the transcriptional signature that
is conveyed to the ICM. The Oct4-TN that we described
provides a useful resource to 1) further study the
mechanisms of Oct4 function and regulation during the
maternal-to-embryo transition; 2) explore the link
between the regulation of pluripotency and the acquisi-
tion of dedifferentiation in cancer cells; 3) improve our
understanding of the molecular factors that contribute
Figure 7 The Oct4-TN genes expressed in MII oocytes and in 2-cell embryos. Black frame, 80 Oct4-OETN genes expressed in both MII
oocytes and 2-cell embryos; highlighted in yellow, Oct4.
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to the mammalian egg developmental competence and
give opportunities for testing new prognostic molecular
markers of oocyte quality in animal and human assisted
reproduction.
Methods
Oocytes isolation, culture to the MII stage and to the 2-
cell embryo
Research on mice has been performed after the approval
of the Animal Ethics Committee of the University of
Pavia. Animals were maintained according to the Guide
for Care and Use of Laboratory Animals. Fully matured
antral oocytes were isolated from the ovaries of 4-6
week-old B6C3F1 female mice (Charles River, Come,
Italy) injected with 3.5 I.U. PMSG (Folligon, Intervet Srl,
Italy) and those that had an NSN type of chromatin
organisation [16] were cultured to the MII stage [17].
MIINSN and MIIctrl oocytes were inseminated with
sperm isolated from the epidydymes of 5 month-old
B6C3F1 male mice [24] and those that reached the 2-
cell stage, 26 hr after insemination, were further treated
for microarray or qRT-PCR analyses.
Microarray-based global gene expression analysis
Total messenger RNA (mRNA) was isolated using the
RNeasy mini kit (Qiagen, USA) and quality-checked by
Nanodrop analysis (Nanodrop Technologies, Wilming-
ton, DE, USA). 400ng of mRNA was used as input for
generating biotin-labelled cRNA. Two rounds of mRNA
amplification were performed using the Illumina Total-
Prep RNA Amplification Kit (Ambion, Austin, TX, Uni-
ted States), which is a complete system for generating
biotinylated, amplified RNA for hybridisation with Illu-
mina Sentrix arrays. cRNA samples were then hybri-
dised onto Illumina mouse-8 BeadChips version 3.
Hybridizations, washing, Cy3-streptavidin staining and
scanning were performed on the Illumina BeadStation
500 platform (Illumina, San Diego, CA, USA), according
to the manufacturer’s instruction. The following samples
were hybridised: one 2-cellctrl and two 2-cellNSN (2-
cellNSN-a and 2-cellNSN-b). Expression data analysis was
carried out using the BeadStudio software 3.0 (Illumina,
San Diego, CA, USA). The raw microarrays data have
been deposited in Gene Expression Omnibus (GEO)
with the following GEO accession number, GSE28704.
Bioinformatic analysis
Raw data were background-subtracted, normalized using
the “rank invariant” algorithm and filtered for significant
expression on the basis of negative control beads. Genes
were considered significantly expressed with detection p
values ≤ 0.01. Differential expression analysis was per-
formed with a fold change threshold of 1.5 (Additional
file 10).
GO enrichment analysis, file management, network
generation and other statistical analysis were performed
with Python scripts that integrates several functions pro-
vided by the Bioinformatics extension of the Orange
Data Mining Suite http://www.ailab.si/orange/.
The enriched GO biological terms were determined
using the entire mouse genome as a reference set. A
threshold of 0.01 on the enrichment p values was set as
a measure of statistical significance. The enriched GO
processes were further automatically classified into a set
of macro categories defined by the domain experts.
The annotation network that was used to infer tran-
scriptional relationships within the Oct4-TN was gener-
ated through a literature-based search strategy. This
methodology retrieved all the PubMed publications
related to the genes in the mouse genome and assigned
to each gene a set of MeSH and GO annotation terms.
A text-mining method based on the annotation terms
was used to calculate the similarity between genes [109].
For each pair of genes in the TN, a connecting link was
created if the annotation similarity exceeded a cut-off
value of 0.7.
Cancer-related genes were identified from experiments
in EBI Atlas database by setting a p value threshold of
0.05.
Real-time polymerase chain reaction
Total RNA was extracted separately from 10 embryos in
3 μl of Lysis Buffer [110]. Retrotranscription was per-
formed in a 20 μl reaction mixture containing: 3 μl of
RNA, 1× PCR buffer, 5 mM MgCl2, 4 mM of each
dNTP, 0.625 μM oligo d(T)16, 1.875 μM Random
Figure 8 OCT4-regulated genes expressed in eggs, 2-cell
embryos and ESCs. This core Oct4-TN may provide a link between
eggs, early preimplantation embryos and ESCs.
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Hexamers, 20 U RNase Inhibitor, 50 U MuLV reverse
transcriptase (Applera). The reverse transcription was
performed at 25°C for 10 min, 42°C for 60 min, 99°C
for 5 min. A mixture of the cDNA products from the
10 embryos was generated and one twentieth of the
resulting cDNA was amplified in duplicate by Real-Time
PCR in 20 μl reaction mixture with 200 nM of each spe-
cific primer (Additional file 11) and the MESA GREEN
qPCR MasterMix Plus for SYBR assay no ROX sample
(Eurogentec) at 1× as final concentration. The amplifica-
tion reaction was performed in a Rotorgene 6000 (Cor-
bett Life Science) as follows: 95°C for 5 min, followed by
40 cycles at 95°C for 10 sec, 60°C for 15 sec, 72°C for 20
sec. The Rotorgene 6000 Series Software 1.7 was used
for the comparative concentration analysis. Htatsf1 gene
expression was used for the normalisation of the
samples.
Immunofluorescence analysis
Oocytes and embryos were fixed with freshly prepared 4%
paraformaldehyde for 20 min, permeabilised with 0.5% Tri-
ton X-100 for 20 min at 4°C and treated with 0.5% block-
ing reagent (Roche, Boston, MA) in TNT (0.1 M, Tris-
HCl, pH 7.5, 0.15 M NaCl, 0.05% Tween-20) buffer for 20
min at 4°C. Immunostaining was performed with rabbit
anti-RPS20 polyclonal antibody (Abcam; ab74700, 1:2000),
rabbit anti-DNMT3L polyclonal antibody (Abcam; ab3493,
1:500) or rabbit anti-MCL1 monoclonal antibody (Abcam;
ab32087, 1:20) for 1 h at 37°C. Primary antibodies were
detected using a secondary Alexa Fluor488-goat anti-rabbit
IgG (Molecular Probes; 1:400 diluted in PBT: 1× PBS plus
0.1% Tween 20) antibody for 1 h at 37°C. Samples were
then washed in PBT (three times) for 15 min at 4°C, coun-
terstained with DAPI (0.2 μg/ml in PBS for 5 min) and
mounted in Vectashield (Vector).
Additional material
Additional file 1: GO enrichment. List of regulated genes (MIINSN vs.
MIIctrl).
Additional file 2: GO enrichment. List of regulated genes (2-cellNSN vs.
2-cellctrl)
Additional file 3: qRT-PCR expression profile of Oct4 and five Oct4-
regulated genes. This analysis confirmed the down-regulated pattern of
expression detected by microarray analysis when comparing 2-cellNSN vs.
2-cellctrl embryos.
Additional file 4: Gene annotation similarity network. Gene
annotation similarity network made of 312 genes retrieved when
exploring the public databases for GO and MeSH links between the
group of 32 Oct4-regulated genes and all the annotated mouse gene
sequences. Green lines, MeSH annotations; orange lines, MeSH and GO
annotations; grey lines, GO annotations. Increasing line width indicates
stronger annotation relationship. Red dot, Oct4 gene.
Additional file 5: Oct4 transcriptional network in MII oocytes. Genes
expressed exclusivelly in MII oocytes. Green box, down-regulated; red
box, up-regulated.
Additional file 6: Oct4 transcriptional network in 2-cell embryos.
Genes expressed exclusivelly in 2-cell embryos. Green box, down-
regulated; red box, up-regulated.
Additional file 7: Main characteristics of the Oct4-OETN genes. Main
characteristics of the genes found in each of the 18 gene clusters.
Additional file 8: List of cancer-related genes present in the
expanded Oct4-TN. The majority of the genes belonging to the
expanded Oct4-TN were recognised as cancer-related genes.
Additionalfile 9: List of cancer-related genes present in the Oct4-
OETN. The majority of the genes belonging to the Oct4-OETN were
recognised as cancer-related genes.
Additional file 10: Microarray analysis. Microarray analysis of 2-cell
embryos.
Additional file 11: RT-PCR primers. List of primers used for the real
time RT-PCR analysis.
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